Abstract
As the age of women undergoing IVF increases, the most common cause of repeated implantation failure has become ovarian dysfunction. A breakthrough treatment is needed to restore decreased ovarian function, improve oocyte quality and quantity, or resume ovulation in premature ovarian insufficiency (POI). The purpose of this study was to determine the efficacy of intraovarian autologous platelet-rich plasma (PRP) on ovarian folliculogenesis in women with poor ovarian responder (POR) and POI
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
